Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
24-26 June, 2025
Not Confirmed
Not Confirmed
06-08 June, 2025
Not Confirmed
Not Confirmed
09-11 June, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 June, 2025
Industry Trade Show
Not Confirmed
06-08 June, 2025
Industry Trade Show
Not Confirmed
09-11 June, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/excipient-market-overview-roquette-announces-restructuring-post-iff-pharma-buyout-who-fda-advance-regulatory-frameworks
08 May 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/nuvalent-outlines-recent-pipeline-and-business-progress-reiterates-key-anticipated-milestones-and-reports-first-quarter-2025-financial-results-302449963.html
29 Apr 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/nuvalent-announces-publication-in-molecular-cancer-therapeutics-reinforcing-rational-molecular-design-of-zidesamtinib-as-a-novel-ros1-selective-inhibitor-302441619.html
01 Apr 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/nuvalent-to-participate-in-the-stifel-2025-virtual-targeted-oncology-forum-302416418.html
25 Mar 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/nuvalent-to-present-new-preclinical-data-on-alk-selective-inhibitor-neladalkib-and-ros1-selective-inhibitor-zidesamtinib-at-aacr-annual-meeting-2025-302411308.html
13 Jan 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/nuvalent-details-strategy-to-seek-first-potential-approval-in-2026-and-outlines-key-anticipated-2025-milestones-302348717.html
19 Dec 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/nuvalent-to-present-at-the-43rd-annual-jp-morgan-healthcare-conference-302335786.html
ABOUT THIS PAGE